Abstract
Hypertrophic scar (HTS) represents the dermal equivalent of fibroproliferative disorders that occur after injury involving the deep dermis while superficial wounds to the skin heal with minimal or no scarring. HTS is characterized by progressive deposition of collagen that occurs with high frequency in adult dermal wounds following traumatic or thermal injury. Increased levels of transforming growth factor-β1 (TGF-β1), decreased expression of small leucine-rich proteoglycans (SLRPs), and/or fibroblast subtypes may influence the development of HTS. The development of HTS is strongly influenced by the cellular and molecular properties of fibroblast subtypes, where cytokines such as fibrotic TGF-β1 and CTGF as well as the expression of SLRPs, particularly decorin and fibromodulin, regulate collagen fibrillogenesis and the activity of TGF-β1. Reduced anti-fibrotic molecules in the ECM of the deep dermis and the distinctive behavior of the fibroblasts in this region of the dermis which display increased sensitivity to TGF-β1’s biological activity contribute to the development of HTS following injury to the deep dermis. By comparing the cellular and molecular differences involved in deep and superficial wound healing in an experimental wound scratch model in humans that has both superficial and deep injuries within the same excisional model, our aim is to increase our understanding of how tissue repair following injury to the deep dermis can be changed to promote healing with a similar pattern to healing that occurs following superficial injury that results in no or minimal scarring. Studying the characteristics of superficial dermal injuries that heal with minimal scarring will help us identify therapeutic approaches for tissue engineering and wound healing. In addition, our ability to develop novel therapies for HTS is hampered by limitations in the available animal models used to study this disorder in vivo. We also describe a nude mouse model of transplanted human skin that develops a hypertrophic proliferative scar consistent morphologically and histologically with human HTS, which can be used to test novel treatment options for these dermal fibrotic conditions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wang J, Dodd C, Shankowsky HA et al (2008) Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88:1278
Gallant CL, Olson ME, Hart DA (2004) Molecular, histologic and gross phenotype of skin wound healing in red Duroc pigs reveals an abnormal healing phenotype of hypercontracted, hyperpigmented scarring. Wound Repair Regen 12:305
Sappino AP, Masouye I, Saurat JH et al (1990) Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol 137:585
Wrana JL, Attisano L, Cárcamo J et al (1992) TGF-beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003
Souchelnytskyi S, Rönnstrand L, Heldin CH et al (2001) Phosphorylation of Smad signalling proteins by receptor serine/threonine kinases. Methods Mol Biol 124:107
Hildebrand A, Romaris M, Rasmussen LM et al (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527
Soo C, Hu FY, Zhang X et al (2000) Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 157:423
Kolb M, Margetts PJ, Sime PJ et al (2001) Proteoglycans decorin and biglycan differentially modulate TGFβ-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280:1327
Sorrell JM, Baber MA, Caplan AI (2004) Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol 200:134
Hagood JS, Lasky JA, Nesbitt JE et al (2001) Differential expression, surface binding, and response to connective tissue growth factor in lung fibroblast subpopulations. Chest 120:64
Zhou Y, Hagood JS, Murphy-Ullrich JE (2004) Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 165:659
Hagood JS, Prabhakaran P, Kumbla P et al (2005) Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol 167:365
Dunkin CS, Pleat JM, Gillespie PH et al (2007) Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 119:1722
Honardoust D, Varkey M, Hori K et al (2011) Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen 19:368–378
Ali-Bahar M, Bauer B, Tredget EE, Ghahary A (2004) Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 12(2):175–182
Kitano Y, Okada N (1983) Separation of the epidermal sheet by dispase. Br J Dermatol 108(5):555–560
Schönherr E, Beavan LA, Hausser H, Kresse H, Culp LA (1993) Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro. Biochem J 290(Pt 3):893–899
Mustoe TA, Cooter RD, Gold MH et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110:560–571
Scott PG, Dodd CM, Tredget EE et al (1995) Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars. Histopathology 26:423
Oliveira GV, Hawkins HK, Chinkes D et al (2009) Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens. Int Wound J 6:445
Mohan RR, Gupta R, Mehan MK et al (2010) Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res 91:238
Stoff A, Rivera AA, Mathis JM et al (2007) Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med 85:481
Shah M, Foreman DM, Ferguson MW (1995) Neutralization of TGF-β 1 and TGF-β 2 or exogenous addition of TGF-β 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985
Pohlers D, Brenmoehl J, Löffler I et al (2009) TGF-beta and fibrosis in different organs—molecular pathway imprints. Biochim Biophys Acta 1792:746
Bandyopadhyay B, Fan J, Guan S, Li Y et al (2006) A “traffic control” role for TGF-beta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 172:1093
Honardoust D, Eslami A, Larjava H, Häkkinen L (2008) Localization of small leucine-rich proteoglycans and transforming growth factor-beta in human oral mucosal wound healing. Wound Repair Regen 16:814
Colwell AS, Yun R, Krummel TM et al (2007) Keratinocytes modulate fetal and postnatal fibroblast transforming growth factor-beta and Smad expression in co-culture. Plast Reconstr Surg 119:1440
Goldberg SR, McKinstry RP, Sykes V et al (2007) Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression. J Pediatr Surg 42:966
Keeley EC, Mehrad B, Strieter RM (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 101:613
Yang L, Scott PG, Dodd C et al (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13:398
Wang J, Jiao H, Stewart TL et al (2007) Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes. J Interferon Cytokine Res 27:921
Acknowledgements
The wound healing research in the author’s laboratory is funded by the Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research, and Firefighters’ Burn Trust Fund of the University of Alberta.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Honardoust, D., Kwan, P., Momtazi, M., Ding, J., Tredget, E.E. (2013). Novel Methods for the Investigation of Human Hypertrophic Scarring and Other Dermal Fibrosis. In: Gourdie, R., Myers, T. (eds) Wound Regeneration and Repair. Methods in Molecular Biology, vol 1037. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-505-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-62703-505-7_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-504-0
Online ISBN: 978-1-62703-505-7
eBook Packages: Springer Protocols